INTEGRATED BIOPHARMA, INC. (INBP) Revenue 2018–2026
INTEGRATED BIOPHARMA, INC. (INBP) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$43.9MFY2026 · since FY2018: $43.7M → $43.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $43.9M | -19.3% |
| FY2025 | $54.4M | +8.0% |
| FY2024 | $50.3M | -0.7% |
| FY2023 | $50.7M | -9.9% |
| FY2022 | $56.2M | -11.5% |
| FY2021 | $63.6M | +20.4% |
| FY2020 | $52.8M | +5.6% |
| FY2019 | $50.0M | +14.3% |
| FY2018 | $43.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More INBP financial trends
INBP Net incomeINBP Net marginINBP Gross profitINBP Gross marginINBP Operating incomeINBP Operating marginINBP Operating cash flowINBP Free cash flowINBP Capital expendituresINBP Return on equityINBP Stock buybacksINBP Dividends paidINBP Total assetsINBP Total liabilitiesINBP Shareholders’ equityINBP overview →